Reversible dementia secondary to topiramate

Clinical Neuropharmacology

Volumn 31, Issue 1, 2008, Pages 62-

  Sempere, Angel P ^a   Medrano, Vicente ^b   Berenguer Ruiz, Leticia ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^b HOSPITAL GENERAL DE ELDA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

SERTRALINE; TOPIRAMATE;

AGED; CASE REPORT; CLINICAL FEATURE; DEMENTIA; DEPRESSION; DRUG DOSE TITRATION; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; MINI MENTAL STATE EXAMINATION; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; DEMENTIA; DEPRESSIVE DISORDER; FEMALE; FRUCTOSE; HUMANS;

EID: 40049086050     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/wnf.0b013e31815947b6     Document Type: Letter

References (5)

1. Moore AR, O'Keeffe ST. Drug-induced cognitive impairment in the elderly. Drugs Aging 1999;15:15-28.
2. Spina E, Perugi G. Antiepileptic drugs: indications other than epilepsy. Epileptic Disord 2004;6:57-75.
3. Martin R, Kuzniecky R, Ho S, et al. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology 1999;52:321-327.
4. Jansen JF, Aldenkamp AP, Marian Majoie HJ, et al. Functional MRI reveals declined prefrontal cortex activation in patients with epilepsy on topiramate therapy. Epilepsy Behav 2006;9:181-185.
5. Stephen LJ, Brodie MJ. Epilepsy in elderly people. Lancet 2000;355:1441-1446.